RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
La Jolla Pharmaceutical Stock

La Jolla Pharmaceutical ROCE 2024

La Jolla Pharmaceutical ROCE

-0.33

Ticker

LJPC

ISIN

US5034596040

WKN

A1XB6B

In 2024, La Jolla Pharmaceutical's return on capital employed (ROCE) was -0.33, a 0% increase from the 0 ROCE in the previous year.

La Jolla Pharmaceutical Aktienanalyse

What does La Jolla Pharmaceutical do?

La Jolla Pharmaceutical Co is a biopharmaceutical company specializing in the development and marketing of medicines for the treatment of rare and severe diseases. It was founded in 1989 in San Diego, California, by physician and scientist Ivor Royston. The company's business model is focused on researching, developing, and marketing drugs for patients with rare or severe diseases. The company prioritizes the needs and requirements of patients and aims to tailor each medication to maximize effectiveness. La Jolla's main focus is on researching medications for severe and rare diseases such as sepsis, acute kidney failure, and lung inflammation. These medications are intended to help patients who have limited or no treatment options. The company's portfolio includes various drugs, with antibodies being an important component for the treatment of inflammation and autoimmune diseases. Notably, Giapreza is one of the company's well-known medications approved by the FDA in December 2017, designed to treat adult patients with severe or most severe septic shock by increasing blood pressure. LJPC-401 is another significant medication developed by La Jolla Pharmaceutical Co, intended for the treatment of lupus nephritis, an autoimmune-related kidney inflammation that affects about 50% of systemic lupus erythematosus (SLE) patients. The company is also working on the development of a medication for migraine treatment, aiming to reduce the severity and frequency of migraine attacks. Overall, La Jolla Pharmaceutical Co has made significant progress in expanding its research activities and is committed to developing innovative medications to improve the lives of patients with rare and severe diseases. The company's focus on patient needs has proven to be a strategic advantage, positioning it competitively for the future. La Jolla Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling La Jolla Pharmaceutical's Return on Capital Employed (ROCE)

La Jolla Pharmaceutical's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing La Jolla Pharmaceutical's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

La Jolla Pharmaceutical's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in La Jolla Pharmaceutical’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about La Jolla Pharmaceutical stock

What is the ROCE (Return on Capital Employed) of La Jolla Pharmaceutical this year?

The ROCE of La Jolla Pharmaceutical is -0.33 undefined this year.

How has the ROCE (Return on Capital Employed) of La Jolla Pharmaceutical developed compared to the previous year?

The ROCE of La Jolla Pharmaceutical has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of La Jolla Pharmaceutical?

A high Return on Capital Employed (ROCE) indicates that La Jolla Pharmaceutical has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of La Jolla Pharmaceutical?

A low ROCE (Return on Capital Employed) can indicate that La Jolla Pharmaceutical has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from La Jolla Pharmaceutical impact the company?

An increase in the ROCE of La Jolla Pharmaceutical can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of La Jolla Pharmaceutical affect the company?

A decrease in ROCE of La Jolla Pharmaceutical can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of La Jolla Pharmaceutical?

Some factors that can affect La Jolla Pharmaceutical's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of La Jolla Pharmaceutical so important for investors?

The ROCE of La Jolla Pharmaceutical is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can La Jolla Pharmaceutical take to improve the ROCE?

To improve the ROCE, La Jolla Pharmaceutical can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does La Jolla Pharmaceutical pay?

Over the past 12 months, La Jolla Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, La Jolla Pharmaceutical is expected to pay a dividend of 0 USD.

What is the dividend yield of La Jolla Pharmaceutical?

The current dividend yield of La Jolla Pharmaceutical is .

When does La Jolla Pharmaceutical pay dividends?

La Jolla Pharmaceutical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of La Jolla Pharmaceutical?

La Jolla Pharmaceutical paid dividends every year for the past 0 years.

What is the dividend of La Jolla Pharmaceutical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is La Jolla Pharmaceutical located?

La Jolla Pharmaceutical is assigned to the 'Health' sector.

Wann musste ich die Aktien von La Jolla Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of La Jolla Pharmaceutical from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did La Jolla Pharmaceutical pay the last dividend?

The last dividend was paid out on 9/10/2024.

What was the dividend of La Jolla Pharmaceutical in the year 2023?

In the year 2023, La Jolla Pharmaceutical distributed 0 USD as dividends.

In which currency does La Jolla Pharmaceutical pay out the dividend?

The dividends of La Jolla Pharmaceutical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The La Jolla Pharmaceutical stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von La Jolla Pharmaceutical

Our stock analysis for La Jolla Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of La Jolla Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.